REVERSED

1600 Biotechnology and Organic Chemistry
Ex Parte Johnston et al MILLS 112(1)/101 ANDRUS, SCEALES, STARKE & SAWALL, LLP

Ex Parte Jones et al ADAMS 103(a) FULBRIGHT & JAWORSKI L.L.P.

1700 Chemical & Materials Engineering
Ex Parte Mathea OWENS 103(a) KLAUS J. BACH

Ex Parte Neumann et al KIMLIN 103(a) GREENBLUM & BERNSTEIN, P.L.C.

Ex Parte Waki GAUDETTE 103(a) MCDERMOTT WILL & EMERY LLP

Ex Parte Van Damme et al GARRIS 103(a) AGFA c/o KEATING & BENNETT, LLP

Ex Parte Font et al KIMLIN 112(1)/112(2)/103(a) OWENS CORNING

2100 Computer Architecture and Software
Ex Parte Gruber et al SIU 103(a) DICKSTEIN SHAPIRO LLP

Ex Parte Zhang et al DIXON 102(e)/102(b) SUGHRUE-265550

AFFIRMED-IN-PART

1600 Biotechnology and Organic Chemistry
Ex Parte Zhang et al GREEN 112(1)/112(2)/102(e) SHERIDAN ROSS PC

In In re Petering, 301 F.2d 676 (CCPA 1962), the court noted that the description of a broad generic formula, without more, even though encompassing Appellants’ claims, did not serve as an anticipatory disclosure. Id. at 681.

Petering, In re, 301 F.2d 676, 133 USPQ 275 (CCPA 1962) . . . . . 2131.02, 2131.03, 2144.08